Results 151 to 160 of about 6,065,276 (313)

СиÑÑема пожаÑной Ð¾Ñ ÑÐ°Ð½Ñ Ð¿ÑедпÑиÑÑиÑ

, 2017
Георгий Константинович Яшин
openalex   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

ÐеÑекÑÑÑ ÑÑÑка Ñ Ð½Ð¾Ð²Ð¾Ð½Ð°ÑÐ¾Ð´Ð¶ÐµÐ½Ð¸Ñ Ð´ÑÑей

, 2015
P. S. Rusak
openalex   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

D. Seifried, N. Stark: Energiedienstleistungen

Technikfolgenabschätzung – Theorie und Praxis, 1994
TATuP editorial office
doaj   +1 more source

ÐлÑнÑко-ÑеÑнологÑÑÐ½Ñ Ð²Ð»Ð°ÑÑивоÑÑÑ Ð¾ÑÐ½Ð¾Ð²Ð½Ð¸Ñ Ð¼Ð°ÑеÑÑалÑв, ÑÐºÑ Ð²Ð¸ÐºÐ¾ÑиÑÑовÑÑÑÑÑÑ Ð² оÑÑопедиÑнÑй ÑÑомаÑологÑÑ

, 2014
Д. Д. Кіндій, В. Д. Кіндій, М. М. Малюченко   +2 more
openalex   +2 more sources

ДејÑтво на интерферон врз фагоцитоза на леукоцитите во in vitro уÑлови [PDF]

, 2016
In atempt to get elementary insight of interpheron action on leukocyte fagocytable capacity, in vitro were tested fagocytes from the patients with various diseases.
УгринÑки (Ugrinski), Предраг (Predrag), Младеновиќ (Mladenovikj), ДрагоÑлав (Dragoslav)   +1 more
core   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Augmented sets of output differences and new distinguishers for SPN ciphers

Scientific Reports
We introduce augmented vector spaces of output differences, new generic and black-box distinguishers for Substitution Permutation Network (SPN) ciphers.
Rahul Girme, Raghvendra Rohit, Santanu Sarkar   +2 more
doaj   +1 more source

Ð¢ÐµÑ Ð½Ð¾Ð»Ð¾Ð³Ð¸Ñ Ð¸Ð·Ð³Ð¾ÑÐ¾Ð²Ð»ÐµÐ½Ð¸Ñ Ñзла ÑÑдового Ð¼ÐµÑ Ð°Ð½Ð¸Ð·Ð¼Ð° по наÑÑÑÐ½Ð¾Ð¼Ñ Ð¾Ð±ÑазÑÑ Ð² ÑÑловиÑÑ ÑемонÑа

, 2016
Николай Николаевич Сучков
openalex   +1 more source